Mount Sinai Creates Platform to Link Genetic Information With EMRs
announced that 25,000 individuals have agreed to participate in its biobank program, which aims at linking a person's genetic information with a range of clinical and environmental information stored in his or her electronic medical record.
The program, called BioMe, uses a new platform called "Clinical Implementation of Personalized Medicine through Electronic Health Records and Genomics" or CLIPMERGE to communicate with the EMR and give physicians real-time guidance based on a patient's genetic profile. Currently, real-time feedback for therapies, based on DNA, is only available for cardiovascular disease, blood clots and high cholesterol.
More Articles on Mount Sinai Medical Center:Mount Sinai Medical Center Promotes Alex Mendez to Executive VP, CFO
Mount Sinai Medical Center Unveils $440M Hess Center, New Logo
Spreading Ideas About Healthcare's Future: Q&A With Dr. Kenneth Davis, President and CEO of The Mount Sinai Medical Center
© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
New From Becker's Hospital CIO